Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-90.28	-11.27	115.96
Graham Fair Price	35.81	42695.65	31438.05
PEG	-70.11	0.32	1.08
Price/Book	-8.81	1.81	1.99
Price/Cash Flow	-37.25	86.06	137.14
Prices/Earnings	-50.30	28.34	57.03
Price/Sales	-7.11	9.78	10.52
Price/FCF	-37.25	86.06	137.14
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	8.85	0.71	0.65
Operating Margin	3664.32	-0.84	0.02
ROA	80.35	0.01	< 0.005
ROE	< 0.005	0.02	83.49
ROIC	< 0.005	-0.11	12305.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	0.01	713.55
Dividends QOQ	-1.00	-1.00	< 0.005
EBIT QOQ	0.20	-38.05	19079.62
EPS QOQ	0.53	0.87	66.30
FCF QOQ	2.59	0.46	-82.37
Revenue QOQ	0.04	-0.02	-62.48
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	109.81	128.43	16.96
Days Sales Outstanding (DSO)	33.20	34.04	2.52
Inventory Turnover	0.82	0.70	-14.50
Debt/Capitalization	0.07	0.06	-8.83
Quick Ratio	1.87	1.81	-3.12
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	70961.50	71145.27	0.26
Cash	17043.81	18646.68	9.40
Capex	-763.87	-433.36	43.27
Free Cash Flow	1029.58	1500.15	45.70
Revenue	13416.49	13205.71	-1.57
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.40	2.33	-2.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.89	0.36	-80.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating